Aranthan Jones II is Chief Corp. Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA). They have made 7 open-market trades across 1 company since 2020, most recently 2021-09-15.
CIK 0001785894
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VNDA | 81,980 | $331K |
Shares reported on the most recent Form 4, priced at the 2021-09-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNDA | SELL | 2021-09-15 | 2021-09-17 | $16.49 | $555K | +2.3% | +8.7% | -1.7% |
| VNDA | SELL | 2021-07-26 | 2021-07-27 | $19.69 | $286K | -16.9% | -13.7% | -5.8% |
| VNDA | SELL | 2021-03-15 | 2021-03-16 | $17.72 | $319K | -10.5% | -2.9% | +11.7% |
| VNDA | SELL | 2021-03-02 | 2021-03-03 | $18.04 | $139K | +0.3% | -10.6% | +0.6% |
| VNDA | SELL | 2021-02-24 | 2021-02-26 | $20.01 | $920K | -4.5% | -19.2% | -3.3% |
| VNDA | SELL | 2020-08-12 | 2020-08-14 | $11.81 | $85K | -10.5% | -15.8% | +11.4% |
| VNDA | SELL | 2020-07-27 | 2020-07-29 | $10.62 | $155K | +19.2% | +3.4% | +5.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.